Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.

Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.
复制标题

DOI:
10.1038/bjc.2011.133
复制
发表时间:
2011-05-10
影响因子:
8.8
通讯作者:
Williams, K. P.
Williams, K. P.
中科院分区:
医学1区
文献类型:
--
作者:
Thomas, Z. I.;Gibson, W.;Sexton, J. Z.;Aird, K. M.;Ingram, S. M.;Aldrich, A.;Lyerly, H. K.;Devi, G. R.;Williams, K. P.

文献摘要

参考文献

被引文献

相似文献

炎症性乳腺癌(IBC)是乳腺癌的一种侵袭性亚型,具有不同的分子特征。基因表达谱以前发现sonic hedgehog(SHH)是IBC患者差异调控的基因信号的一部分。采用免疫印迹法、四甲基偶氮唑盐比色法、Annexin-V/PI法、常规细胞迁移实验和自动细胞迁移实验检测GLI1对细胞蛋白表达、细胞增殖、细胞凋亡和迁移的影响。对一组乳腺癌细胞株的评估显示,在对ErbB1/2靶向策略产生抗药性的三阴性、高侵袭性IBC细胞系SUM149及其同基因衍生的rSUM149中,GLI1表达升高,这通常是刺激性信号通路激活的标志。用小干扰RNA或小分子GLI1抑制剂下调SUM149和rSUM149细胞中GLI1的表达,可抑制细胞增殖,促进细胞凋亡。此外,与低GLI1表达的非侵袭性细胞株MCF-7相比,这些细胞系中GLI1的抑制显著抑制了细胞的迁移,这一点通过伤口愈合试验进行了评估。一种新的高含量迁移试验使我们能够量化GLI1沉默的多种影响,包括显着减少细胞移动距离和运动的线性。我们的数据揭示了GLI1在IBC细胞的增殖、存活和迁移中的作用,这支持了将GLI1作为IBC患者的一种新的治疗策略的可行性。
Inflammatory breast cancer (IBC) is an aggressive subtype of breast cancer with distinct molecular profiles. Gene expression profiling previously identified sonic hedgehog (SHH) as part of a gene signature that is differentially regulated in IBC patients. The effects of reducing GLI1 levels on protein expression, cell proliferation, apoptosis and migration were determined by immunoblots, MTT assay, Annexin-V/PI assay and conventional and automated cell migration assays. Evaluation of a panel of breast cancer cell lines revealed elevated GLI1 expression, typically a marker for hedgehog-pathway activation, in a triple-negative, highly invasive IBC cell line, SUM149 and its isogenic-derived counterpart rSUM149 that has acquired resistance to ErbB1/2 targeting strategies. Downregulation of GLI1 expression in SUM149 and rSUM149 by small interfering RNA or a small molecule GLI1 inhibitor resulted in decreased proliferation and increased apoptosis. Further, GLI1 suppression in these cell lines significantly inhibited cell migration as assessed by a wound-healing assay compared with MCF-7, a non-invasive cell line with low GLI1 expression. A novel high-content migration assay allowed us to quantify multiple effects of GLI1 silencing including significant decreases in cell distance travelled and linearity of movement. Our data reveal a role for GLI1 in IBC cell proliferation, survival and migration, which supports the feasibility of targeting GLI1 as a novel therapeutic strategy for IBC patients.
DOI: 10.1158/1535-7163.mct-07-0370
发表时间: 2008-01-01
影响因子: 5.7
作者:
Aird, Katherine M.;Ding, Xiuyun;Devi, Gayathri R.
通讯作者: Devi, Gayathri R.
DOI: 10.1038/sj.bjc.6695007
发表时间: 1999-12
影响因子: 8.8
作者:
Forozan, F;Veldman, R;Ammerman, CA;Parsa, NZ;Kallioniemi, A;Kallioniemi, OP;Ethier, SP
通讯作者: Ethier, SP
DOI: 10.1074/jbc.m109.021949
发表时间: 2009-08-21
影响因子: 4.8
作者:
Das, Shamik;Harris, Lillianne G.;Shevde, Lalita A.
通讯作者: Shevde, Lalita A.
DOI: 10.1186/gb-2006-7-10-r100
发表时间: 2006
期刊: Genome biology
影响因子: 12.3
作者:
Carpenter AE;Jones TR;Lamprecht MR;Clarke C;Kang IH;Friman O;Guertin DA;Chang JH;Lindquist RA;Moffat J;Golland P;Sabatini DM
通讯作者: Sabatini DM
DOI: 10.1158/0008-5472.can-07-0491
发表时间: 2007-07-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Dennler, Sylviane;Andre, Jocelyne;Mauviel, Alain
通讯作者: Mauviel, Alain